#United States #Princeton #BioCentriq #Cell Therapy #Made Scientific

Introduction

In a bold move that aims to redefine the landscape of cell therapy, BioCentriq has recently undergone a rebranding and is now known as Made Scientific. This transition comes as part of the organization’s mission to accelerate the journey of life-saving cell therapies from initial development to commercial delivery. Made Scientific is focused on streamlining complex processes and overcoming obstacles in the industry, ensuring that breakthroughs in cell therapies are rapidly accessible to patients.

The Meaning Behind the Name

The new name, Made Scientific, stands for Manufacturing and Development Excellence. This change symbolizes a renewed commitment from the organization to lead in the fields of cell therapy development and manufacturing. According to Syed T. Husain, Chairman and CEO of Made Scientific, the company has dedicated significant time to listen to various stakeholders, including startups, large pharmaceutical companies, and academic institutions. One recurring theme during these discussions was the challenges surrounding scalability, vendor flexibility, and manufacturing readiness within the sector.

Addressing Industry Challenges

Made Scientific aims to tackle these persistent issues head-on. Their innovative business model is designed specifically to fill gaps identified in the market, thereby alleviating real problems for innovators in the field of cell therapy. The company leverages extensive scientific knowledge, cutting-edge technology, and strong leadership to adapt to the evolving needs of their partners.

Facility Enhancements

In conjunction with the rebranding, Made Scientific announced the operational status of its new headquarters and clinical-commercial facility in Princeton, New Jersey, which boasts an impressive 60,000 square feet. This facility is equipped with state-of-the-art amenities, including six independent ISO 7 cleanrooms that feature the latest analytical and manufacturing technologies, such as advanced bioreactors and automated cell processing systems.

A substantial investment of $12 million has been made for facility upgrades, which will further solidify Made Scientific's stance as a formidable player in the quickly expanding cell therapy market. The design of the facility also allows for customizable expansion space, ensuring that Made Scientific can scale operations to meet future demands.

A Comprehensive Service Offering

Made Scientific provides a wide array of services tailored to the unique needs of cell therapy development. Their offerings include:

• - Process and Analytical Development: Streamlining the transition from concept to clinical application.
• - GMP Drug Substance/Product Manufacturing: Delivering high-quality, compliant solutions.
• - GMP Aseptic Fill/Finish: Ensuring product safety and efficacy.
• - Quality Control Release Testing: Maintaining rigorous standards throughout the production process.
• - Stability Studies: Monitoring the durability and viability of products over time.
• - Workforce Development/Training: Empowering teams with necessary skills and knowledge.

Forward-Looking Statements

With its rebranding as Made Scientific, the organization is poised to address existing challenges within the cell therapy landscape while delivering unparalleled service and innovation. Its robust infrastructure and commitment to meeting client needs pave the way for future growth and industry leadership.

Furthermore, Made Scientific operates two U.S.-based manufacturing facilities, combining the agility of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, further enhancing its capabilities.

Conclusion

As Made Scientific embarks on this new chapter, it remains focused on its mission to expedite the breakthrough of effective cell therapies into the hands of those who need them most. Those interested in learning more about Made Scientific and its comprehensive suite of services are encouraged to visit www.madescientific.com.

Made Scientific is setting a new precedence in the cell therapy industry, equipped with the tools, knowledge, and vision necessary to forge a path towards revolutionary advancements in healthcare.